How biologics teams use Dynamic Light Scattering to identify leading candidates

April 17, 2023

Groups in early biologics development and formulation use Dynamic Light Scattering (DLS) to make informed decisions that de-risk downstream biologics development.

Watch this 15 min video to get an overview of how DLS works and how it improves these biologics development processes.

You'll learn:

  • What DLS measures and how it works during a quick refresher
  • What DLS data tells you about your biologics
  • How DLS data from samples with strong or poor colloidal stability looks like
  • How to use DLS to remove candidates with no promise so you can focus on candidates and conditions that have potential

At the end, you'll understand how and when you can add DLS to your early development workflow to de-risk candidate selection.

Why it's important for biologics researchers:

A successful biologic candidate screening campaign depends on having the right tools. When tasked with identifying the most promising biologics candidates, adding DLS gives you more detailed and reliable insights into the purity and colloidal stability of your samples.

To get more detailed information about the physical principles behind Dynamic Light Scattering watch this webinar.

Previous Article
What to consider when adding DLS to your early biologics development workflow
What to consider when adding DLS to your early biologics development workflow

Read on to find the answers to questions your early development scientist peers have asked about how to use...

Up next
How early discovery and development teams use DLS to de⁠-⁠risk downstream biologics development
How early discovery and development teams use DLS to de⁠-⁠risk downstream biologics development

As a discovery or early development scientist, you’re tasked with identifying the most promising biologics ...

Ready to tackle your challenging stability characterizations?

Discover tools